Literature DB >> 6097576

Tuberous sclerosis: case study of early seizure control and subsequent normal development.

V W Lane, J M Samples.   

Abstract

This case study presents the history of a child diagnosed with severe tuberous sclerosis (TS) with an original prognosis of severe to profound mental retardation. Infantile spasms and seizures were eventually controlled, and with educational and therapeutic intervention, this child progressed until she was functioning within normal limits by age 4. This paper presents the position that early diagnosis, early seizure control, and early multidisciplinary intervention are crucial in reducing the poor prognosis in such cases.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6097576     DOI: 10.1007/bf02409832

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  4 in total

1.  Computed tomography in tuberous sclerosis--with special reference to relation between clinical manifestations and CT findings.

Authors:  Y Maki; T Enomoto; H Maruyama; K Maekawa
Journal:  Brain Dev       Date:  1979       Impact factor: 1.961

2.  Family studies in tuberous sclerosis. evaluation of apparently unaffected parents.

Authors:  S B Cassidy; R A Pagon; M Pepin; J D Blumhagen
Journal:  JAMA       Date:  1983-03-11       Impact factor: 56.272

3.  Tuberous sclerosis, early onset of seizures, and mental subnormality: study of discordant homozygous twins.

Authors:  M R Gomez; N L Kuntz; B F Westmoreland
Journal:  Neurology       Date:  1982-06       Impact factor: 9.910

4.  Tuberous sclerosis: early neurologic manifestations and CT features in 18 patients.

Authors:  Y Konishi; M Ito; T Okuno; H Hojo; R Okuda; Y Nakano; J Handa
Journal:  Brain Dev       Date:  1979       Impact factor: 1.961

  4 in total
  1 in total

1.  The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex.

Authors:  F J K O'Callaghan; T Harris; C Joinson; P Bolton; M Noakes; D Presdee; S Renowden; A Shiell; C N Martyn; J P Osborne
Journal:  Arch Dis Child       Date:  2004-06       Impact factor: 3.791

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.